| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/01/1998 | CN1186439A Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 07/01/1998 | CN1038929C Chelants processing ortho ligating functionality and complexes thereof |
| 06/30/1998 | US5773602 DNA fragments obtained from a novel human immunodeficiency virus designated LAVMAL |
| 06/30/1998 | US5773600 DNA encoding pertussis toxin muteins |
| 06/30/1998 | US5773579 Comprising a membrane ion and a phosphorylation site; exhibits carbonic anhydrase activity |
| 06/30/1998 | US5773578 Polypeptides and proteins |
| 06/30/1998 | US5773574 Amino acid sequences for cells derives from fibronectins |
| 06/30/1998 | US5773572 Fragments of prion proteins |
| 06/30/1998 | US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/30/1998 | US5773479 Atherosclerosis, tamoxifen |
| 06/30/1998 | US5773419 Method of treating cancer with tannic acid |
| 06/30/1998 | US5773293 Anti-ICAM-4 antibodies and hybridomas |
| 06/30/1998 | US5773292 Ablate or kill cancer cells |
| 06/30/1998 | US5773280 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses |
| 06/30/1998 | US5773250 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae |
| 06/30/1998 | US5773247 Recombinant anti-HIV antibody and process for preparing the same |
| 06/30/1998 | US5773237 Method for determining tyrosine kinase activity |
| 06/30/1998 | US5773235 Equine arteritis virus peptides; antibodies and their use in a diagnostic test |
| 06/30/1998 | US5773230 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 06/30/1998 | US5773228 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
| 06/30/1998 | US5773218 Method to identify compounds which modulate ICAM-related protein interactions |
| 06/30/1998 | US5773011 Method of preparing a synergistic immunological adjuvant formulation |
| 06/30/1998 | US5773010 Low molecular weight allergen obtained from Dermatophagoides farinae |
| 06/30/1998 | US5773009 Rotavirus strain G9P11 |
| 06/30/1998 | US5773007 Vaccine compositions |
| 06/30/1998 | US5773006 Lipsome containing IL-2 |
| 06/30/1998 | US5773002 Miticides |
| 06/30/1998 | US5773001 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 06/30/1998 | US5773000 Therapeutic treatment of clostridium difficile associated diseases |
| 06/30/1998 | US5772999 Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals |
| 06/30/1998 | US5772997 Monoclonal antibodies directed to the HER2 receptor |
| 06/30/1998 | US5772995 Compositions and methods for enhanced tumor cell immunity in vivo |
| 06/30/1998 | US5772981 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 06/30/1998 | CA2040548C Use of autologous promoters to express gene products in bordetella |
| 06/30/1998 | CA1339937C Procedure for obtaining dna, rna peptides, polypeptides, or proteins by recombinant dna techniques |
| 06/25/1998 | WO1998027433A1 A specific diagnostic for antibodies to feline infectious peritonitis virus |
| 06/25/1998 | WO1998027215A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector |
| 06/25/1998 | WO1998027208A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF |
| 06/25/1998 | WO1998027111A1 Vaccine for the reversible immunocastration of mammals |
| 06/25/1998 | WO1998027110A2 Dihydroxypropyl cysteine peptide and agent containing this peptide |
| 06/25/1998 | WO1998027107A1 Method of coupling polysaccharides to proteins |
| 06/25/1998 | WO1998026801A1 Agent for identifying and treating metastasizing tumours |
| 06/25/1998 | WO1998026800A1 In ovo vaccination against newcastle disease |
| 06/25/1998 | WO1998026799A1 Conjugate vaccine for salmonella paratyphi a |
| 06/25/1998 | WO1998026798A2 IMMUNIZATION AGAINST NEISSERIA GONORRHOEAE AND $i(NEISSERIA MENINGITIDIS) |
| 06/25/1998 | WO1998026790A1 Mycobacterium vaccae for down-regulation of the th2 activity of the immune system |
| 06/25/1998 | WO1998026747A2 Superantigen based methods and compositions for treatment of diseases |
| 06/25/1998 | WO1998022100A3 New use for 1,3-propanediol derivatives |
| 06/25/1998 | WO1998021364A3 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 06/25/1998 | WO1998012220A3 Novel tumor proteins |
| 06/25/1998 | WO1998001154A3 Treatment and diagnosis of infections of gram positive cocci |
| 06/25/1998 | DE19652815A1 Mittel zur Identifizierung und Therapie metastasierender Tumore Means for the identification and treatment of metastatic tumors |
| 06/25/1998 | CA2275440A1 Vaccine for the reversible immunocastration of mammals |
| 06/24/1998 | EP0849362A2 Streptococcus proteins of the spoT/relA family (spo/rel) |
| 06/24/1998 | EP0849361A2 Novel ligands of the neuropeptide receptor HFGAN72 |
| 06/24/1998 | EP0848956A1 In ovo vaccination against Newcastle Disease |
| 06/24/1998 | EP0848756A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 06/24/1998 | EP0848752A1 Method for purifying viruses by chromatography |
| 06/24/1998 | EP0848615A1 Multi-subtype fiv vaccines |
| 06/24/1998 | EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 06/24/1998 | EP0751785B1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 06/24/1998 | CN1185811A Antigen presentation system on retrovirus-like particles |
| 06/24/1998 | CN1185810A Synthetic HPV6/11 hybrid L1 DNA encoding human papliomavirus type 11 L1 protein |
| 06/24/1998 | CN1185806A New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (PRRS), vaccines and diagnostic means obtainable with said strain, and production process |
| 06/24/1998 | CN1185740A Chlamydia vaccines |
| 06/23/1998 | US5770719 Isolated nucleic acid containing promoter sequence from a gene which codes for an adenosine triphosphatase |
| 06/23/1998 | US5770703 Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene |
| 06/23/1998 | US5770698 Process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
| 06/23/1998 | US5770689 Hepatitis E virus ORF Z peptides |
| 06/23/1998 | US5770444 Growth differentiation factor-6 |
| 06/23/1998 | US5770427 Retrovirus from the HIV group and its use |
| 06/23/1998 | US5770403 Genetically engineered nucleic acid coding for antibodies which bind to and block interleukins |
| 06/23/1998 | US5770396 Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E |
| 06/23/1998 | US5770366 Melanoma-inhibiting protein |
| 06/23/1998 | US5770357 Method of diagnosing caprine arthritis-encephalitis virus infection |
| 06/23/1998 | US5770234 Particle induced amplification of immune response |
| 06/23/1998 | US5770222 Therapeutic drug delivery systems |
| 06/23/1998 | US5770214 Vaccines containing salmonella bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway |
| 06/23/1998 | US5770213 Endotoxin-free; otitis media, sinusitis, meningitis, and chronic pulmonary obstructive disease |
| 06/23/1998 | US5770212 Recombinant poxviruses with foreign DNA in essential regions |
| 06/23/1998 | US5770211 Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease |
| 06/23/1998 | US5770210 Expression of htlv-iii envelope proteins by recombinant dna methods, aids vaccine |
| 06/23/1998 | US5770209 Acceleration of wound healing using connective tissue growth factor |
| 06/23/1998 | US5770208 Staphylococcus aureus B-linked hexosamine antigen |
| 06/23/1998 | US5770203 Modified cholera toxin based on mutagenized subunit A |
| 06/23/1998 | US5770202 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 06/23/1998 | US5770201 HA-2 antigenic peptide |
| 06/23/1998 | US5770199 Method for virus inactivation in the presence of polyalkylene glycol as well as the pharmaceutical preparation obtained therewith |
| 06/23/1998 | US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | US5770195 Antitumor |
| 06/23/1998 | CA2222823A1 Composition of slap-130, a slp-76 associated protein and methods of use therefor |
| 06/23/1998 | CA2079887C Purification of a pertussis outer membrane protein |
| 06/23/1998 | CA2038579C Utilization of enzymes |
| 06/20/1998 | CA2202322A1 Conserved metalloprotease epitopes |
| 06/18/1998 | WO1998026075A1 Non-m non-o hiv strains, fragments and applications |
| 06/18/1998 | WO1998026074A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine |
| 06/18/1998 | WO1998026067A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | WO1998026050A2 Glutathionylspermidine synthetase |
| 06/18/1998 | WO1998026049A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |